Drugs / Elo-Mel Isoton
last change Mar 2016 re-read 2 minutes ago

Elo-Mel Isoton

Developed for
critical illness polyneuropathy

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02414555 Comparator Mar 2015 → Mar 2016 critical illness polyneuropathy Medical University of Vienna Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Elo-Mel Isoton ClinicalTrials.gov intervention name — accepted as the source's own label NCT02414555